rs132630284
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000533.5(PLP1):c.607G>A(p.Asp203Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D203E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000533.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLP1 | NM_000533.5 | c.607G>A | p.Asp203Asn | missense_variant | 4/7 | ENST00000621218.5 | NP_000524.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLP1 | ENST00000621218.5 | c.607G>A | p.Asp203Asn | missense_variant | 4/7 | 1 | NM_000533.5 | ENSP00000484450.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 04, 2018 | The D203N pathogenic variant in the PLP1 gene has been reported previously, using alternate nomenclature D202N, in a male with Pelizaeus-Merzbacher disease (Mimault et al., 1999). Functional studies show D203N is retained in the endoplasmic reticulum and forms fewer crosslinks between PLP and DM20, with the authors concluding that D203N disrupts the formation of a disulfide bridge in PLP/DM20 that is required for normal protein folding and trafficking (Dhaunchak and Nave, 2007; Dhaunchak et al., 2011). The D203N variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The D203N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. We interpret D203N as a pathogenic variant. - |
Pelizaeus-Merzbacher disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 07, 2018 | The PLP1 c.607G>A p.(Asp203Asn) missense variant , also known as p.(Asp202Asn), has been previously reported in one study where it was identified in one affected male with Pelizaeus-Merzbacher disease (PMD) (Mimault et al. 1999). Additionally, at least four other missense variants resulting in alternate amino acid changes at the 203 residue have been identified in individuals with PMD in the literature (Doll et al. 1992, Nagao et al. 1998, Mimault et al. 1999, Cailloux et al. 2000). This variant is not observed in version 2.1.1 of the Genome Aggregation Database. Expression of the p.(Asp203Asn) variant in various cell lines, including oli-neu, an oligodendrocyte cell line, revealed retention of the PLP1 protein in the endoplasmic reticulum (ER), which were rescued by cysteine to serine substitutions in the neighboring residues. It is postulated that p.(Asp203Asn) variant in the large extracellular loop 2 of the protein, induces minor structural changes that prevent efficient formation of normal disulfide bridges, which exposes unpaired cysteines in the oxidative environment of the ER and competing oxidations generate aberrant PLP dimers that fail to mature into oligomeric forms and are retained in the ER (Dhaunchak and Nave 2007, Dhaunchak et al. 2011). Based on the collective evidence, the c.607G>A p.(Asp203Asn) variant is classified as pathogenic for Pelizaeus-Merzbacher disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at